Kawasaki Medical School is a private university in Kurashiki, Japan, established in April 1970.

During the past decade, Kawasaki Medical School conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kawasaki Medical School" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Ministry of Health, Labour and Welfare, Japan" with 3 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Chugai Pharmaceutical" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kawasaki Medical School" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator, "Asakayama Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Kawasaki Medical School" are "Chronic Kidney Disease" (2 trials), "Coronary Artery Disease" (2 trials), "Eosinophilic Esophagitis" (2 trials), "Gastrointestinal Stromal Tumor" (2 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "Kawasaki Medical School" in a lesser frequency.

Most popular intervention types in "Kawasaki Medical School" are "Drug" (20 trials), "Other" (4 trials), "Procedure" (4 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BI 685509" (2 trials), "CC-93538" (2 trials), "Placebo to match SEL 18 mg" (2 trials) and "Placebo to match SEL 6 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kawasaki Medical School" are 26 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Kawasaki Medical School". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Kawasaki Medical School, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kawasaki Medical School, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".